Related references
Note: Only part of the references are listed.From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Zobair M. Younossi et al.
HEPATOLOGY (2021)
Redefining fatty liver disease: an international patient perspective
Gamal Shiha et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
On the Proposed Definition of Metabolic-Associated Fatty Liver Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi et al.
GUT (2020)
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
James M. Paik et al.
HEPATOLOGY (2020)
Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016
M. H. Le et al.
JOURNAL OF INTERNAL MEDICINE (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016
B. Zou et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study
Jovan Julien et al.
Lancet Public Health (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Underestimation of alcohol consumption in cohort studies and implications for alcohol's contribution to the global burden of disease
Tim Stockwell et al.
ADDICTION (2018)
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICS IN LIVER DISEASE (2018)
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Marie Boyle et al.
JOURNAL OF HEPATOLOGY (2018)
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
Pegah Golabi et al.
MEDICINE (2018)
Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in US adults
Toshihiro Umehara
PLOS ONE (2018)
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
Donghee Kim et al.
GASTROENTEROLOGY (2018)
Comparison of Laboratory Tests, Ultrasound, or Magnetic Resonance Elastography to Detect Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xiao et al.
HEPATOLOGY (2017)
Is Moderate Alcohol Use in Nonalcoholic Fatty Liver Disease Good or Bad? A Critical Review
Veeral H. Ajmera et al.
HEPATOLOGY (2017)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population
Raxitkumar Jinjuvadia et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
Michael H. Le et al.
PLOS ONE (2017)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Statin use is not associated with liver related mortality
Zahra Younoszai et al.
ANNALS OF HEPATOLOGY (2014)
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994
Mariana Lazo et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
Zobair M. Younossi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
Yi Chen et al.
EUROPEAN JOURNAL OF CANCER (2012)
Economic Costs of Excessive Alcohol Consumption in the US, 2006
Ellen E. Bouchery et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2011)
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Maria Stepanova et al.
GUT (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
S. C. Larsson et al.
BRITISH JOURNAL OF CANCER (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Share Paper
